Recent advances in chitosan-based nanoparticles for oral delivery of macromolecules

被引:361
作者
Chen, Mei-Chin [1 ]
Mi, Fwu-Long [2 ]
Liao, Zi-Xian [3 ]
Hsiao, Chun-Wen [3 ]
Sonaje, Kiran [3 ]
Chung, Min-Fan [3 ]
Hsu, Li-Wen [3 ]
Sung, Hsing-Wen [3 ]
机构
[1] Natl Cheng Kung Univ, Dept Chem Engn, Tainan, Taiwan
[2] Taipei Med Univ, Coll Med, Sch Med, Dept Biochem, Taipei, Taiwan
[3] Natl Tsing Hua Univ, Dept Chem Engn, Hsinchu 30013, Taiwan
关键词
Oral drug delivery; Transcellular pathway; Paracellular pathway; Bioavailability; Mucoadhesion; Tight junction; IN-VITRO EVALUATION; CACO-2 CELL MONOLAYERS; PALMITOYL GLYCOL CHITOSAN; PERORAL PEPTIDE DELIVERY; DRUG-DELIVERY; INSULIN DELIVERY; GENE DELIVERY; THIOLATED POLYMERS; EPITHELIAL-CELLS; ABSORPTION ENHANCEMENT;
D O I
10.1016/j.addr.2012.10.010
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Chitosan (CS), a cationic polysaccharide, is widely regarded as a safe and efficient intestinal absorption enhancer of therapeutic macromolecules, owing to its inherent mucoadhesive feature and ability to modulate the integrity of epithelial tight junctions reversibly. By using CS-based nanoparticles, many studies have attempted to protect the loaded macromolecules against acidic denaturation and enzymatic degradation, prolong their intestinal residence time, and increase their absorption by the intestinal epithelium. Derivatives of CS such as quaternized CS, thiolated CS and carboxylated CS have also been examined to further enhance its effectiveness in oral absorption of macromolecular drugs. This review article describes the synthesis of these CS derivatives and their characteristics, as well as their potential transport mechanisms of macromolecular therapeutics across the intestinal biological membrane. Recent advances in using CS and its derivatives as carriers for oral delivery of hydrophilic macromolecules and their effects on drug transport are also reviewed. (C) 2012 Elsevier B.V. All rights reserved.
引用
收藏
页码:865 / 879
页数:15
相关论文
共 172 条
[1]   Bioavailability of nanoparticles in nutrient and nutraceutical delivery [J].
Acosta, Edgar .
CURRENT OPINION IN COLLOID & INTERFACE SCIENCE, 2009, 14 (01) :3-15
[2]   PASSIVE DIFFUSION OF WEAK ORGANIC ELECTROLYTES ACROSS CACO-2 CELL MONOLAYERS - UNCOUPLING THE CONTRIBUTIONS OF HYDRODYNAMIC, TRANSCELLULAR, AND PARACELLULAR BARRIERS [J].
ADSON, A ;
BURTON, PS ;
RAUB, TJ ;
BARSUHN, CL ;
AUDUS, KL ;
HO, NFH .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1995, 84 (10) :1197-1204
[3]   Preparation and characterization of protein-loaded N-trimethyl chitosan nanoparticles as nasal delivery system [J].
Amidi, M ;
Romeijn, SG ;
Borchard, G ;
Junginger, HE ;
Hennink, WE ;
Jiskoot, W .
JOURNAL OF CONTROLLED RELEASE, 2006, 111 (1-2) :107-116
[4]   Chitosan-based delivery systems for protein therapeutics and antigens [J].
Amidi, Maryam ;
Mastrobattista, Enrico ;
Jiskoot, Wim ;
Hennink, Wim E. .
ADVANCED DRUG DELIVERY REVIEWS, 2010, 62 (01) :59-82
[5]  
Andrade F, 2011, NANOMEDICINE-UK, V6, P123, DOI [10.2217/nnm.10.143, 10.2217/NNM.10.143]
[6]   Effect of preparation conditions on properties and permeability of chitosan-sodium hexametaphosphate capsules [J].
Angelova, N ;
Hunkeler, D .
JOURNAL OF BIOMATERIALS SCIENCE-POLYMER EDITION, 2001, 12 (12) :1317-1337
[7]  
Arai K., 1986, B TOKAI REG FISH RES, V56, P889
[8]  
Arbit Ehud, 2004, Diabetes Technol Ther, V6, P510, DOI 10.1089/1520915041705929
[9]   Diethyl methyl chitosan as an intestinal paracellular enhancer: ex vivo and in vivo studies [J].
Avadi, MR ;
Jalali, A ;
Sadeghi, AMM ;
Shamimi, K ;
Bayati, KH ;
Nahid, E ;
Dehpour, AR ;
Rafiee-Tehrani, M .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2005, 293 (1-2) :83-89
[10]   25 YEARS OF SALMON-CALCITONIN - FROM SYNTHESIS TO THERAPEUTIC USE [J].
AZRIA, M ;
COPP, DH ;
ZANELLI, JM .
CALCIFIED TISSUE INTERNATIONAL, 1995, 57 (06) :405-408